Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Self-reported immunity and opinions on vaccination of hospital personnel among paediatric healthcare workers in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Authors' reply

    Research output: Contribution to journalComment/debateResearch

  3. Are refugees arriving in Denmark an under-immunised group for measles? A cross-sectional serology study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Bacille Calmette-Guérin vaccination at birth and differential white blood cell count in infancy. A randomised clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Endometrial cancer risk after fertility treatment: a population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Gynaecological cancer leads to long-term sick leave and permanently reduced working ability years after diagnosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Prevalence of human papillomavirus in oral epithelial dysplasia: Systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  • Charlene A Wong
  • Mona Saraiya
  • Susan Hariri
  • Linda Eckert
  • Roberta I Howlett
  • Lauri E Markowitz
  • Julia M L Brotherton
  • Katy Sinka
  • Olga G Martinez-Montañez
  • Susanne K Kjaer
  • Eileen F Dunne
View graph of relations
In this review, we describe plans to monitor the impact of human papillomavirus (HPV) vaccine on biologic outcomes in selected international areas (Australia, Canada, Mexico, the Nordic countries, Scotland, and the United States) that have adopted this vaccine. This summary of monitoring plans provides a background for discussing the challenges of vaccine monitoring in settings where resources and capacity may vary. A variety of approaches that depend on existing infrastructure and resources are planned or underway for monitoring HPV vaccine impact. Monitoring HPV vaccine impact on biologic outcomes is a complex and challenging task, but also plays an important role in documenting the benefit of vaccination, monitoring the progress of vaccination programs, and providing data to inform vaccination and disease prevention policies.
Original languageEnglish
JournalVaccine
Volume29
Issue number5
Pages (from-to)878-85
Number of pages8
ISSN0264-410X
DOIs
Publication statusPublished - 29 Jan 2011

ID: 32314873